Adam Soloff

Assistant Professor

University of Pittsburgh School of Medicine

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Adam Soloff is an Assistant Professor at the University of Pittsburgh School of Medicine, USA. His research primarily focuses on the tumor microenvironment, immunotherapy resistance, and the role of macrophages in various cancers. Notable recent publications include studies on macrophage behavior in triple-negative breast cancer and the impact of interleukin-2 on antitumor responses in metastatic cancer.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (2)

Laura Stabile

Associate Professor

University of Pittsburgh

UNITED STATES

View details

Julie E. Bauman

The George Washington University School of Medicine and Health SCiences

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Adam Soloff

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

<i>CDKN2A</i><sup>Low</sup> cancer cells outcompete macrophages for microenvironmental zinc to drive immunotherapy resistance

Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease

A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients

HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer

Orchestrating Resilience: How Neuropilin-2 and Macrophages Contribute to Cardiothoracic Disease

Sexual dimorphism in lung cancer susceptibility and macrophage immunopathology in response to environmental respiratory hazards

Tumor cell p38 inhibition to overcome immunotherapy resistance

Cellular Indoctrination: How the Tumor Microenvironment Reeducates Macrophages Towards Nefarious Ends

EXTRAFOLLICULAR EXPANSION AND DIFFERENTIATION OF B CELLS DRIVES ANTI-TUMOR RESPONSES IN METASTATIC CANCER

Intrapleural interleukin-2-expressing oncolytic virotherapy enhances acute antitumor effects and T-cell receptor diversity in malignant pleural disease

Prognostic Difference of Pleural versus Distant Metastasis after Surgery for Lung Cancer

Characteristics of Malignant Pleural Effusion Resident CD8<sup>+</sup> T Cells from a Heterogeneous Collection of Tumors

Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck Cancer

Collaborators (2)

Laura Stabile

Julie E. Bauman

Make your next move.